Department of Ophthalmology, St Thomas' Hospital, London, SE1 7EH, UK.
King's College London, London, SE1 7EH, UK.
Eye (Lond). 2021 Sep;35(9):2499-2505. doi: 10.1038/s41433-020-01260-9. Epub 2020 Nov 6.
High intensity focused ultrasound (HiFU) is a cyclodestructive therapy for controlling intraocular pressure (IOP) in glaucoma. The mechanism of action is thought to be through destruction of the ciliary epithelium as well as increased uveoscleral outflow. We reviewed the change in aqueous humour dynamics parameters including aqueous humour flow rate, tonographic outflow facility (TOF) and uveoscleral outflow at 12 months.
This is a prospective observational study. Consecutive patients with open angle glaucoma (OAG) or ocular hypertension (OHT) requiring further IOP lowering were enroled in the study between August 2016 and January 2017. Patients were commenced on medication washout period prior to baseline and twelve months' visit.
Sixteen patients (OAG) in the treatment group underwent assessment at twelve months follow up. Mean age was 63.1 ± 11 years. Eleven patients were African/Caribbean and 5 were Caucasian. Nine patients were female and 7 were male. Mean post-washout IOP was reduced by 21% (28.3 ± 5.7 at baseline vs 22.4 ± 8.4 mmHg at 12 months, p = 0.04). Aqueous humour flow rate was reduced by 16% at twelve months (2.40 ± 0.6 at baseline vs 2.02 ± 0.6 µl/min at 12 months, p = 0.0493). There was no statistically significant change in the TOF (0.12 ± 0.09 at baseline vs 0.08 ± 0.05 µl/min/mmHg at 12 months, p = 0.08) or uveoscleral outflow (0.6 ± 1.3 at baseline vs 1.3 ± 0.85 µl/min at 12 months, p = 0.15).
In this study, we demonstrated that the observed IOP reduction was likely due to aqueous humour flow rate reduction. The TOF and uveoscleral outflow were not detectibly changed.
高强度聚焦超声(HiFU)是一种用于控制青光眼眼内压(IOP)的环破坏性疗法。其作用机制被认为是通过破坏睫状上皮以及增加葡萄膜巩膜外流。我们回顾了 12 个月时房水动力学参数的变化,包括房水流量、眼压流出率(TOF)和葡萄膜巩膜外流。
这是一项前瞻性观察性研究。2016 年 8 月至 2017 年 1 月期间,连续纳入需要进一步降低 IOP 的开角型青光眼(OAG)或高眼压症(OHT)患者。患者在基线和 12 个月就诊前进行药物洗脱期。
16 例(OAG)治疗组患者在 12 个月时进行了评估。平均年龄为 63.1±11 岁。11 例为非洲/加勒比裔,5 例为白种人。9 例为女性,7 例为男性。洗脱后平均眼压降低 21%(基线时为 28.3±5.7mmHg,12 个月时为 22.4±8.4mmHg,p=0.04)。12 个月时房水流量降低 16%(基线时为 2.40±0.6µl/min,12 个月时为 2.02±0.6µl/min,p=0.0493)。TOF 无统计学意义变化(基线时为 0.12±0.09µl/min/mmHg,12 个月时为 0.08±0.05µl/min/mmHg,p=0.08)或葡萄膜巩膜外流(基线时为 0.6±1.3µl/min,12 个月时为 1.3±0.85µl/min,p=0.15)。
在这项研究中,我们发现观察到的眼压降低可能是由于房水流量减少所致。TOF 和葡萄膜巩膜外流没有明显变化。